Omeros Corp (OMER)
3.22
-0.12
(-3.59%)
USD |
NASDAQ |
Apr 18, 16:00
3.22
0.00 (0.00%)
After-Hours: 20:00
Omeros Cash from Operations (TTM): 74.73M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 74.73M |
September 30, 2023 | 84.17M |
June 30, 2023 | 90.38M |
March 31, 2023 | 103.25M |
December 31, 2022 | -86.48M |
September 30, 2022 | -79.32M |
June 30, 2022 | -76.54M |
March 31, 2022 | -84.66M |
December 31, 2021 | -109.72M |
September 30, 2021 | -109.91M |
June 30, 2021 | -121.19M |
March 31, 2021 | -131.20M |
December 31, 2020 | -100.09M |
September 30, 2020 | -104.69M |
June 30, 2020 | -77.27M |
March 31, 2020 | -56.27M |
December 31, 2019 | -60.07M |
September 30, 2019 | -61.72M |
June 30, 2019 | -91.07M |
March 31, 2019 | -105.39M |
December 31, 2018 | -103.74M |
September 30, 2018 | -83.25M |
June 30, 2018 | -57.57M |
March 31, 2018 | -34.82M |
December 31, 2017 | -36.23M |
Date | Value |
---|---|
September 30, 2017 | -42.92M |
June 30, 2017 | -42.94M |
March 31, 2017 | -47.58M |
December 31, 2016 | -51.50M |
September 30, 2016 | -57.24M |
June 30, 2016 | -60.61M |
March 31, 2016 | -64.36M |
December 31, 2015 | -65.21M |
September 30, 2015 | -64.30M |
June 30, 2015 | -65.65M |
March 31, 2015 | -64.38M |
December 31, 2014 | -58.04M |
September 30, 2014 | -42.65M |
June 30, 2014 | -37.74M |
March 31, 2014 | -31.87M |
December 31, 2013 | -29.70M |
September 30, 2013 | -42.18M |
June 30, 2013 | -38.55M |
March 31, 2013 | -38.01M |
December 31, 2012 | -34.55M |
September 30, 2012 | -29.13M |
June 30, 2012 | -25.83M |
March 31, 2012 | -23.30M |
December 31, 2011 | -25.67M |
September 30, 2011 | -11.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-131.20M
Minimum
Mar 2021
103.25M
Maximum
Mar 2023
-52.51M
Average
-79.32M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Aspira Womens Health Inc | -15.89M |
Ardelyx Inc | -89.72M |
Panbela Therapeutics Inc | -25.25M |
Ensysce Biosciences Inc | -10.78M |
MAIA Biotechnology Inc | -13.07M |